Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Angiotensin II receptor blockers (ARBs), also known as angiotensin II receptor antagonists, AT1 receptor antagonists or sartans, are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
Market Analysis and Insights: Global Angiotensin Receptor Blockers (ARBs) Market
The global Angiotensin Receptor Blockers (ARBs) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Angiotensin Receptor Blockers (ARBs) Scope and Market Size
The global Angiotensin Receptor Blockers (ARBs) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Angiotensin Receptor Blockers (ARBs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Angiotensin Receptor Blockers (ARBs) market is segmented into
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Segment by Application, the Angiotensin Receptor Blockers (ARBs) market is segmented into
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
The Angiotensin Receptor Blockers (ARBs) market is analysed and market size information is provided by regions (countries). Segment by Application, the Angiotensin Receptor Blockers (ARBs) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Angiotensin Receptor Blockers (ARBs) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiotensin Receptor Blockers (ARBs) business, the date to enter into the Angiotensin Receptor Blockers (ARBs) market, Angiotensin Receptor Blockers (ARBs) product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Market Analysis and Insights: Global Angiotensin Receptor Blockers (ARBs) Market
The global Angiotensin Receptor Blockers (ARBs) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Angiotensin Receptor Blockers (ARBs) Scope and Market Size
The global Angiotensin Receptor Blockers (ARBs) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Angiotensin Receptor Blockers (ARBs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Angiotensin Receptor Blockers (ARBs) market is segmented into
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
Segment by Application, the Angiotensin Receptor Blockers (ARBs) market is segmented into
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
The Angiotensin Receptor Blockers (ARBs) market is analysed and market size information is provided by regions (countries). Segment by Application, the Angiotensin Receptor Blockers (ARBs) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape
and Angiotensin Receptor Blockers (ARBs) Market Share AnalysisAngiotensin Receptor Blockers (ARBs) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiotensin Receptor Blockers (ARBs) business, the date to enter into the Angiotensin Receptor Blockers (ARBs) market, Angiotensin Receptor Blockers (ARBs) product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
